The Application Notebook
Ultra fast separations of acetaminophen, caffeine, propofol and parabens are achieved in 30 s using the Thermo Scientific Accela UHPLC system with the 80 Hz PDA detector. The performance of the Accela PDA detector is highlighted by its low noise level, low drift, four orders of magnitude linear working range and high sensitivity.
Guifeng Jiang, Yenny Chan and Andre J. Nohl, Thermo Fisher Scientific Inc., San Jose, California, USA.
Ultra fast separations of acetaminophen, caffeine, propofol and parabens are achieved in 30 s using the Thermo Scientific Accela UHPLC system with the 80 Hz PDA detector. The performance of the Accela PDA detector is highlighted by its low noise level, low drift, four orders of magnitude linear working range and high sensitivity.
Detector noise and drift
The drift was measured at flow rate of 1000 μL/min with a constant flow of 100% methanol. The drift value for the PDA detector was 0.1 mAU/h.
The reduction in the level of noise increased detector sensitivity. The level of noise of the PDA detector was lower when the detector was operated at lower data sampling rates and/or higher rise times. The levels of noise of four different data rates (5, 20, 40, 80 Hz) were 1.1, 4.5, 14.8 and 43.1 μAU respectively.
Data sampling rate optimization
In general, about 20 data points per peak is required for reproducible quantification. High data sampling rates resulted in increased noise reducing sensitivity. Eight pharmaceutical small molecules were separated in 30 s using LC gradient method I and a BDS 50 × 4.6 mm column with elution order of uracil, acetaminophen, caffeine, methylparaben, ethylparaben, propylparaben, butylparaben and propofol (Figure 1). Similar peak width and peak resolution were obtained with 40 Hz and 80 Hz data sampling rates, indicating that both rates were suitable for this chromatographic separation. The 40 Hz data sampling rate was preferred here for its lower noise level and better sensitivity.
Figure 1
Detector linearity and sensitivity
High throughput UHPLC completes separations in tens of seconds and improves sensitivity resulting in sharper, taller and better resolved peaks.
Calibration curves of the four compounds were constructed over the concentration range of 39–300000 ng/mL with 11 calibration levels. Correlation coefficients were achieved 0.999 or better for all four compounds with four orders of magnitude linearity working range.
The Accela PDA detector acquires data at sampling rates up to 80 Hz for UHPLC high throughput separations with independent setting of diode rates, data sampling rates and rise time. Using the current UHPLC instrumentation and sub-2 μm particle columns, the PDA detector provided sufficient data point to define a chromatographic peak with peak width as narrow as 0.166 s. The four orders of magnitude linear working range and the ppb (ng/mL) level sensitivity for the PDA detector ensured the low level determination and quantification of the target compounds in UHPLC high throughput analyses.
Accela is a trademark of Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc.
2215 Grand Avenue Parkway, Austin, Texas 78728, USA
tel. +1 800 532 4752 fax +1 561 688 8731
Website: www.thermo.com
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
Inside the Laboratory: The Richardson Group at the University of South Carolina
November 20th 2024In this edition of “Inside the Laboratory,” Susan Richardson of the University of South Carolina discusses her laboratory’s work with using electron ionization and chemical ionization with gas chromatography–mass spectrometry (GC–MS) to detect DBPs in complex environmental matrices, and how her work advances environmental analysis.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
Infographic: Be confidently audit ready, at any time and reduce failures in pharma QC testing
November 20th 2024Discover how you can simplify the audit preparation process with data integrity dashboards that provide transparency to key actions, and seamlessly track long-term trends and patterns, helping to prevent system suitability failures before they occur with waters_connect Data Intelligence software.
Critical Role of Oligonucleotides in Drug Development Highlighted at EAS Session
November 19th 2024A Monday session at the Eastern Analytical Symposium, sponsored by the Chinese American Chromatography Association, explored key challenges and solutions for achieving more sensitive oligonucleotide analysis.